Reducing tuberculosis incidence in HIV-infected patients by tuberculin skin testing, preventive treatment, and antiretroviral therapy [7]

Clinical Infectious Diseases

Volumn 44, Issue 10, 2007, Pages 1393-1394

  Hamlyn, Elizabeth ^a   Childs, Kate ^a   Post, Frank A ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID;

CHEMOPROPHYLAXIS; DISEASE ASSOCIATION; DISEASE TRANSMISSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; SCREENING; TREATMENT FAILURE; TUBERCULIN TEST; TUBERCULOSIS;

COHORT STUDIES; HIV; HIV INFECTIONS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 34248201037     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516608     Document Type: Letter

References (4)

1. Elzi L, Schlegel M, Weber R, et al. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis 2007; 44:94-102.
2. Whalen CC, Johnson JL, Okwera A, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. N Engl J Med 1997; 337:801-8.
3. Rose DN. Short-course prophylaxis against tuberculosis in HIV-infected persons: a decision and cost-effectiveness analysis. Ann Intern Med 1998; 129:779-86.
4. Chapman AL, Munkanta M, Wilkinson KA, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 2002; 16:2285-93.